InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: misiu143 post# 35034

Monday, 02/04/2019 1:51:00 AM

Monday, February 04, 2019 1:51:00 AM

Post# of 232963
Totally agree. The biggest item that Dr. pestell noted and why he merged his company with CytoDyn is because he stated he not only saw the efficacy side of using CCR5 as a target but Pro-140 had perfect safety profile. That's the problem with many cancer treatments for metastatic disease, patients have to go through chemotherapy which is highly toxic. If pro-140 works out for cancer too that would be amazing for patients not just investors.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News